Price Over Earnings Overview: AstraZeneca
Portfolio Pulse from Benzinga Insights
AstraZeneca Inc.'s (NASDAQ:AZN) share price is currently at $64.33, after a 0.58% increase. Over the past month, the stock decreased by 5.44%, but in the past year, it went up by 4.86%. The company's P/E ratio is 32.38, higher than the aggregate P/E ratio of the Pharmaceuticals industry (30.48), indicating that the stock might be overvalued. The P/E ratio is a useful metric for analyzing a company's market performance, but it should not be used in isolation.
November 06, 2023 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AstraZeneca's share price is at $64.33, up 0.58%. Its P/E ratio of 32.38, higher than the industry average, suggests the stock might be overvalued.
AstraZeneca's P/E ratio is higher than the industry average, which could indicate that the stock is overvalued. However, a high P/E ratio could also mean that investors expect the company to perform better in the future. The stock's price has increased in the current market session, but it has decreased over the past month. Therefore, the short-term impact on the stock's price is neutral.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100